| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 22,961 | 23,471 | 23,931 | 24,567 | | Cost of Revenue | 12,502 | 11,940 | 11,964 | 11,148 | | | Gross Profit | 10,459 | 11,531 | 11,967 | 13,419 | | | Operating Expenses | | Research Development | 1,544 | 1,998 | 1,653 | 2,162 | | Selling General and Administrative | 10,648 | 10,768 | 11,618 | 11,553 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,733) | (1,235) | (1,304) | (296) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 62 | 139 | (67) | 66 | | Earnings Before Interest And Taxes | (1,671) | (1,096) | (1,371) | (230) | | Interest Expense | 358 | 363 | 370 | 368 | | Income Before Tax | (2,029) | (1,459) | (1,741) | (598) | | Income Tax Expense | (122) | (255) | 55 | (189) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,907) | (1,204) | (1,796) | (409) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,907) | (1,204) | (1,796) | (409) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,907) | ($1,204) | ($1,796) | ($409) |
|
0.02% Nasdaq 
0.02 (0.65%) 
Income Statement
